Welcome to CDC stacks | Laboratory medicine best practices : developing systematic evidence review and evaluation : methods for quality improvement phase 3 final technical report - 32830 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Laboratory medicine best practices : developing systematic evidence review and evaluation : methods for quality improvement phase 3 final technical report
  • Published Date:
    May 27, 2010
  • Language:
    English
Filetype[PDF-2.83 MB]


Details:
  • Corporate Authors:
    CDC Laboratory Medicine Best Practices Team. ; Centers for Disease Control and Prevention (U.S.). Office of Surveillance, Epidemiology, and Laboratory Sciences. Laboratory Science, Policy and Practice Program Office. Division of Laboratory Science and Standards. ;
  • Description:
    BACKGROUND AND PURPOSE: This report summarizes the third phase of an ongoing effort sponsored by the Division of Laboratory Science and Standards (DLSS), Centers for Disease Control and Prevention. The purpose is to develop new systematic evidence review and evaluation methods for identifying pre- and post-analytic laboratory medicine practices that are effective at improving healthcare quality.1 This effort began in 2006, when CDC convened the Laboratory Medicine Best Practices Workgroup (Workgroup), a multidisciplinary panel of experts in such fields as laboratory medicine, clinical medicine, health services research, and health care performance measurement. The Workgroup also includes two ex officio representatives from the Centers for Medicare and Medicaid Services (CMS) and the Food and Drug Administration (FDA).

    An outcome of Phase 1 (2006 – 2007) was to act on a Workgroup recommendation to enlarge the search for evidence to unpublished studies, including assessments performed for the purposes of quality assurance, process improvement and/or accreditation documentation. Phase 2 (2007-2008) involved a pilot test of further refined methods to obtain, review, and evaluate published and unpublished evidence, along with collecting observations via key informant interviews about organizational and implementation issues successfully addressed by other recommending bodies about the development and dissemination of guidelines and best practice recommendations. These evidence review methods were adapted from those established by the GRADE group, The Guide to Community Preventive Services (Community Guide), the Agency for Healthcare Research and Quality (AHRQ) (US Preventive Services Task Force (USPSTF), Evidence-based Practice Centers (EPCs), and Effective Healthcare Program), and others, and modified to better accommodate the non-controlled study designs typically found in quality improvement research.

    Phase 3 (2008-2010), the subject of this report, involved further development of methods for identifying evidence-based laboratory medicine quality improvement best practices, and validated these methods with reviews of practices associated with three topics: patient specimen identification, critical value reporting, and reducing blood culture contamination.

    Prepared for: Division of Laboratory Science and Standards, Laboratory Science, Policy and Practice Program Office. Office of Surveillance, Epidemiology, and Laboratory Sciences (OSELS), Centers for Disease Control and Prevention; prepared by the CDC Laboratory Medicine Best Practices Team.

    Contract No. W911NF-07-D-0001 / TCN 08319/DO 0567

    LMBP Yr3 FINAL Technical Report FINAL

  • Document Type:
  • Funding:
    W911NF-07-D-0001 / TCN 08319/DO 0567
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: